Journal
GASTROENTEROLOGY RESEARCH AND PRACTICE
Volume 2013, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2013/804128
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81160255]
- Innovation Program of Guangxi Municipal Education Department [201204LX674]
- Innovation Program of Shanghai Municipal Education Commission [13YZ035]
- Natural Science Foundation of Guangxi [2013GXNSFAA019251]
- Science Foundation of Youjiang Medical College for Nationalities [2005, 2008]
Ask authors/readers for more resources
MicroRNA-429 (miR-429) may modify the development and progression of cancers; however, the role of this microRNA in the hepatocellular carcinoma (HCC) has not been well elaborated. Here, we tested miR-429 expression in 138 pathology-diagnosed HCC cases and SMMC-7721 cells. We found that miR-429 was upregulated in HCC tumor tissues and that the high expression of miR-429 was significantly correlated with larger tumor size (odd ratio (OR), 2.70; 95% confidence interval (CI), 1.28-5.56) and higher aflatoxin B1-DNA adducts (OR = 3.13, 95% CI = 1.47-6.67). Furthermore, this microRNA overexpression modified the recurrence-free survival and overall survival of HCC patients. Functionally, miR-429 overexpression progressed tumor cells proliferation and inhibited cell apoptosis. These results indicate for the first time that miR-429 may modify HCC prognosis and tumorigenesis and may be a potential tumor therapeutic target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available